More Renerve Limited news
Renerve LimitedASX: RNV

ReNerve Clinical Study Expansion

Nov 4, 2025 at 11:03 PM EST · Issued by Renerve Limited

Filed with ASX · Nov 4, 2025 at 11:03 PM EST

On 6ix: 6ix.com/news/renerve-clinical-study-expansion

Renerve Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Renerve Limited on 6ix

Story so far

  • Clinical Outcome Demonstrates Material Benefits for PatientsMar 28, 2025

Earlier from Renerve

  • Q1 FY26 Activities Report and Appendix 4COct 22, 2025
  • ReNerve achieves first sales of amniotic tissue rangeOct 13, 2025
  • Investor Roadshow PresentationSep 28, 2025
  • Empliq Product LaunchSep 22, 2025
  • ReNerve launches the EmpliQ product rangesSep 22, 2025

Later from Renerve

  • Nerve Cuff approved for use in US DoD and VA hospitalsNov 12, 2025
  • Trading HaltNov 17, 2025
  • ReNerve completes $3.2m capital raisingNov 19, 2025
  • ReNerve AGM PresentationNov 26, 2025
  • Broader approval received in Hong Kong for Nerve CuffJan 11
All Renerve news releases↗

Follow Renerve into a list and get an email when it puts out news.

Follow Renerve
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer